Marapharm Ventures (CSE:MDM) announced a fully funded operating agreement with Full Spectrum Medicinal and provided an update on its medical license application.
As quoted in the press release:
Marapharm has taken immediate action to amend two items on its late- stage Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”) application. The Company is currently amending the location for its license application to Celista, BC, FSM’s 40-acre site, 1 hour from Salmon Arm and the new appointment of a Quality Assurance Person (QAP).
10 – 10,000 sq. ft. engineered bio-secure facilities, which have been fully funded by FSM, will be constructed in two phases, ultimately maximizing the potential of our 100,000 [square feet] ACMPR licence once approved by Health Canada. Ground preparation on the site began on August 15.
“As a Canadian based company, we are confident about the demand and anticipated size of the Canadian cannabis market. This strategic alliance is mutually beneficial and will bring great shareholder value.” Linda Sampson, CEO.